Severe influenza treatment guideline

doi:10.3904/kjim.2014.29.1.132

Practice Guideline

. 2014 Jan;29(1):132-47.

doi: 10.3904/kjim.2014.29.1.132. Epub 2014 Jan 2.

Severe influenza treatment guideline

Affiliations

¹ Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
³ Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.
⁴ Department of Internal Medicine, Konkuk University School of Medicine, Chungju, Korea.
⁵ Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
⁶ Gachon University Gil Hospital Cancer Center, Gachon University Gil Medical Center, Incheon, Korea.
⁷ Department of Pediatrics, Eulji University School of Medicine, Daejeon, Korea.
⁸ Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea.
⁹ Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
¹⁰ Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

PMID: 24574848
PMCID: PMC3932389
DOI: 10.3904/kjim.2014.29.1.132

Practice Guideline

Severe influenza treatment guideline

Won Suk Choi et al. Korean J Intern Med. 2014 Jan.

. 2014 Jan;29(1):132-47.

doi: 10.3904/kjim.2014.29.1.132. Epub 2014 Jan 2.

Authors

Affiliations

¹ Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
³ Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.
⁴ Department of Internal Medicine, Konkuk University School of Medicine, Chungju, Korea.
⁵ Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
⁶ Gachon University Gil Hospital Cancer Center, Gachon University Gil Medical Center, Incheon, Korea.
⁷ Department of Pediatrics, Eulji University School of Medicine, Daejeon, Korea.
⁸ Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea.
⁹ Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
¹⁰ Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

PMID: 24574848
PMCID: PMC3932389
DOI: 10.3904/kjim.2014.29.1.132

No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article is reported.

Cited by

Two-stage prediction model for in-hospital mortality of patients with influenza infection.
Cheong CW, Chen CL, Li CH, Seak CJ, Tseng HJ, Hsu KH, Ng CJ, Chien CY. Cheong CW, et al. BMC Infect Dis. 2021 May 19;21(1):451. doi: 10.1186/s12879-021-06169-6. BMC Infect Dis. 2021. PMID: 34011298 Free PMC article.
Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.
Cho SY, Lee HJ, Lee DG. Cho SY, et al. Korean J Intern Med. 2018 Mar;33(2):256-276. doi: 10.3904/kjim.2018.036. Epub 2018 Feb 27. Korean J Intern Med. 2018. PMID: 29506345 Free PMC article. Review.
Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China.
Li Y, He H, Gao Y, Ou Z, He W, Chen C, Fu J, Xiong H, Chen Q. Li Y, et al. Front Med (Lausanne). 2021 Nov 11;8:733999. doi: 10.3389/fmed.2021.733999. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34859002 Free PMC article.
Predictors and Outcomes of Hospitalization for Influenza: Real-World Evidence from the United States Medicare Population.
Bolge SC, Kariburyo F, Yuce H, Fleischhackl R. Bolge SC, et al. Infect Dis Ther. 2021 Mar;10(1):213-228. doi: 10.1007/s40121-020-00354-x. Epub 2020 Oct 27. Infect Dis Ther. 2021. PMID: 33108613 Free PMC article.
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.
Sturm S, Lemenuel-Diot A, Patel K, Gibiansky L, Bhardwaj R, Smith PF, Dang S, Zwanziger E, Nasmyth-Miller C, Ravva P. Sturm S, et al. Br J Clin Pharmacol. 2021 Mar;87(3):1359-1368. doi: 10.1111/bcp.14523. Epub 2020 Sep 9. Br J Clin Pharmacol. 2021. PMID: 32808306 Free PMC article.

See all "Cited by" articles

References

1. Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother. 2012;44:233–249.
1. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses [Internet] Geneva (CH): World Health Organization; c2013. [cited 2013 Oct 2]. Available from: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivira...
1. Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282:1240–1246. - PubMed
1. Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of inf luenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011;55:2803–2812. - PMC - PubMed
1. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute inf luenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355:1845–1850. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother. 2012;44:233–249.

[2] Choi WS, Lee J, Lee HY, et al. Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza. Infect Chemother. 2012;44:233–249.

[3] World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses [Internet] Geneva (CH): World Health Organization; c2013. [cited 2013 Oct 2]. Available from: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivira...

[4] World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses [Internet] Geneva (CH): World Health Organization; c2013. [cited 2013 Oct 2]. Available from: http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivira...

[5] Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282:1240–1246. - PubMed

[6] Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999;282:1240–1246. - PubMed

[7] Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of inf luenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011;55:2803–2812. - PMC - PubMed

[8] Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of inf luenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011;55:2803–2812. - PMC - PubMed

[9] Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute inf luenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355:1845–1850. - PubMed

[10] Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute inf luenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355:1845–1850. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Severe influenza treatment guideline

Affiliations

Severe influenza treatment guideline

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical